UK stocks in decline as US-Europe trade spat worries escalate and coronavirus spread fears take grip

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Major UK indexes remain entrenched in a tailspin at midday on Thursday as investors continue to fret over a possible escalation of a trade dispute between the US and Europe and concerns about the increasing threat from the coronavirus spreading across China and elsewhere.

At 12.10pm, the benchmark FTSE 100 index is down close on 0.3% at 7,551.61, while the mid cap FTSE 250 is off nearly 0.5% at 21,660.63.

Authorities have already suspended planes and trains in and out of Wuhan inChina because of the coronavirus, a city of 11m people, and the travel clampdown has now spread to nearby Huanggang, home to another seven million.

There are more than 500 confirmed cases of the coronavirus, which has already spread abroad.

Major European markets were lower, following Asian indices overnight.

On the UK market, the international travel worries caused by the virus are having an unsurprising impact on airline stocks, with EasyJet and BA-owner International Consolidated Airlines both around 3% down.

Conversely, aero-engine manufacturer Rolls-Royce heads the FTSE 100 leader board, adding 2% at 662.2p.

MAJOR NEWS STORIES

Retail remains firmly in focus after online fashion player ASOS posted better-than-expected revenue. In the four month period encompassing Christmas, the company revealed at 20% jump in sales thanks to a record Black Friday performance.

ASOS shares rose 2.5% to £31.

Also in the space, baby products specialist Mothercare slumped 11% to 14.8p on a reshuffling of senior management with chief executive Mark Newton-Jones stepping down, and finance chief Glyn Hughes taking over as interim chief executive.

The company said its recapitalisation remains on track as it refocuses on international markets.

But more upbeat is chocolatier Hotel Chocolat after the company reported revenue growth of 11% for the 13-weeks to 29 December, and 14% for the 26 weeks. The company said that trading remains in-line with management's expectations.

The positive update was slightly spoiled by the comment that 'the cost to deliver this growth was modestly higher due to inefficiencies in the supply chain which are being addressed in 2020' pushing the shares down 2.3% to 417.5p.

IT reseller Computacenter nudged up 1.3% to £17.83 after it said it expected to report record profit and revenue and reiterated expectations that annual performance would be within the upper end of current market forecasts.

The company said full year results would show its 'best ever' revenue, profit, earnings per share and cash generation. Total revenue for the group grew by 16% and by 17% in constant currency.

Computacenter shares have rallied 79% year to date.

PROPERTY STOCKS IN FOCUS

PPHE Hotel's share price dropped 2% to £20.20 in spite of the company reporting a 6.3% rise in like for life room revenue for the year ended December 31, 2019, in its latest trading update.

Room revenue for the year increased by 5.9% to £250m, while like-for-like RevPAR for the year grew 5.1% to £103.7, driven by like-for-like occupancy growth of 130bps to 80.7% and like-for-like average room rate growth of 3.4% to £128.5.

The trading benefits from the £100m plus multi-year investment and repositioning programme are starting to come through, following the launch of Holmes Hotel London in May, and the reopening of Park Plaza Vondelpark, Amsterdam and Park Plaza Utrecht in October.

Meanwhile, Unite Group has received resolution to grant planning permission for its 416-bed student accommodation in Bristol city centre. The plans incorporate the conversion of the former Georgian hospital building into 62 rented residential homes.

The company's share price dipped 1p to £13.01.

Robot process automation designer Blue Prism saw its share price soar more than 20% to £14.84 after upping full year guidance and impressing investors with its pathway to positive cash flow and profits strategy.

US-based hospitals finance software specialist Craneware plunged 12% to £20.60 as it steered investors to expect flat revenue growth for 2019 after losing a major client. But it does anticipate an improved EBITDA performance of about 10% on 2018.